MarketPulse

financial results

121 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Dominik Slappnig

Sika AG Shareholders Approve Board, Boost Dividend to CHF 3.70 Per Share

Sika AG shareholders approved CHF 3.70 dividend and board re-election at 2026 AGM, with company reporting CHF 11.20B sales and 33,700 employees globally.
SXYAYfinancial resultscorporate governance
GlobeNewswire Inc.GlobeNewswire Inc.··17 Education & Technology Group Inc.

17EdTech Posts Narrower Loss Despite Revenue Decline as AI Product Gains Traction

17EdTech reports Q4 revenue growth of 6.4% YoY and significant margin expansion, though full-year revenues declined 44% due to business model shift. New AI product 'Yiqi Aixue' shows strong pre-sale demand.
YQfinancial resultsnet loss
The Motley FoolThe Motley Fool··Jonathan Ponciano

Slide Insurance Posts $444M Profit on Strong Revenue Growth; Insider Trims Position

Slide Insurance reported $444M net income and $1.16B revenue, up 36% YoY. Director sold $1M in shares via pre-arranged plan while maintaining substantial stake.
SLDEfinancial resultsrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

IMUNON Sets March 31 Call to Detail 2025 Results, OVATION 3 Trial Progress

$IMNN to discuss 2025 results and OVATION 3 Phase 3 trial progress for IMNN-001 ovarian cancer immunotherapy on March 31, 2026.
IMNNPhase 3 clinical trialfinancial results
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inventiva to Report 2025 Results as MASH Drug Candidate Advances

Inventiva will release 2025 financial results March 30, 2026, while advancing lanifibranor in Phase 3 MASH trials.
IVAPhase 3 clinical trialfinancial results
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inventiva to Report 2025 Results as MASH Drug Candidate Advances in Phase 3

Inventiva to release 2025 financial results March 30, 2026, as its lanifibranor MASH drug advances through Phase 3 clinical trials.
IVAPhase 3 clinical trialfinancial results
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Helen of Troy Stock Crashes 25% as Law Firm Launches Fraud Investigation

The Portnoy Law Firm investigates $TROY after 25% stock collapse triggered by disappointing Q2 earnings and major profit decline.
HELEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Byrna Technologies to Report Q1 2026 Results; Earnings Call Scheduled for April 9

Byrna Technologies will report fiscal Q1 2026 financial results on April 9, 2026 at 9:00 a.m. ET via conference call with management Q&A.
BYRNfinancial resultsconference call
BenzingaBenzinga··Schall Law Firm

SES AI Stock Crashes 36.8% After Undisclosed Logistics Failures; Securities Probe Launched

SES AI faces securities investigation after stock plunged 36.8% following March 4 earnings, allegedly due to undisclosed $1.5M shipment delays.
SESSES.WSsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

America's Car-Mart Stock Tanks 18% Amid Loss Expansion; Securities Probe Launched

CRMT shares plummeted 18.2% after reporting Q1 loss of 69 cents per share versus 15 cents prior year. Securities lawsuit investigation underway.
CRMTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Maxim Power Reports Earnings Decline, Advances 400 MW Gas Turbine Project

Maxim Power's 2025 net income fell to $16.7M from $21.9M, while securing GE turbine for Prairie Lights expansion with planned 2026 spending.
GEVfinancial resultspower generation
GlobeNewswire Inc.GlobeNewswire Inc.··Na

BioCardia to Unveil 2025 Results, Corporate Strategy on March 24 Call

BioCardia scheduled conference call for March 24, 2026 to report full-year 2025 financial results and provide corporate update.
BCDAfinancial resultsconference call
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Acumen Pharma to Unveil 2025 Results as Alzheimer's Drug Advances

Acumen Pharmaceuticals will report full-year 2025 financial results on March 26, 2026, as its lead Alzheimer's candidate progresses through Phase 2 trials.
HALOABOSPhase 2 clinical trialfinancial results
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Blink Charging Sets March 26 Earnings Call as EV Charging Sector Heats Up

$BLNK to report Q4 2025 results and full-year financials on March 26, 2026, with investor conference call at 4:30 p.m. ET.
BLNKfinancial resultsearnings announcement
BenzingaBenzinga··The Law Offices Of Frank R. Cruz

Oddity Tech Plunges 49% as Ad Algorithm Changes Trigger $14.74 Stock Collapse

Oddity Tech shares crashed 49% after disclosing algorithm changes from its largest ad partner will trigger 30% Q1 revenue decline, prompting securities fraud investigation.
ODDfinancial resultssecurities fraud investigation
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Tejon Ranch Navigates Proxy Battle While Posting Strong Revenue Growth

Tejon Ranch reported 7% revenue growth to $58.7M in 2025, though net income fell 96% to $0.1M due to $3.4M proxy defense costs.
TRCfinancial resultsreal estate development
GlobeNewswire Inc.GlobeNewswire Inc.··Nrx Pharmaceuticals, Inc.

NRx Pharmaceuticals to Unveil 2025 Results, Update on Breakthrough Psychiatric Drug Pipeline

NRx Pharmaceuticals to report 2025 results March 24, 2026, updating on FDA-designated ketamine and PTSD programs with significant clinical potential.
NRXPNRXPWfinancial resultsclinical-stage biopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Equinor Posts Record Production, $6.4B Net Income Despite Energy Transition Headwinds

Equinor delivers record 2,137 million foe/day production and $6.43B net income in 2025, though renewable expansion plans face delays.
EQNRfinancial resultsrenewable energy
BenzingaBenzinga··Prnewswire

Minerva Foods Posts Record R$54.8B Revenue as Exports Drive 61% Growth

Minerva Foods achieves record R$54.8 billion revenue in 2025, up 61% YoY, with R$848.3 million net income and R$1.5 billion free cash flow.
MRVSYfinancial resultsfree cash flow
BenzingaBenzinga··Prnewswire

TEN Holdings Loses $19.5M in Maiden Year as Public Company Despite Revenue Decline

TEN Holdings reported $3.1M revenues (down 11.4%) and $19.5M net loss in its first year as public company, offset by doubled customer acquisitions and strategic partnerships.
XHLDfinancial resultsnet loss